POSTERIOR SUB-TENON'S Avastin

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Diffuse Diabetic Macular Edema Clinical Trial

Official title:
POSTERIOR SUB-TENON'S CAPSULE INJECTION OF BEVACIZUMAB FOR TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA

Status Withdrawn

Clinical Trial Summary

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema

n/a

NCT number	NCT00567372
Study type	Interventional
Source	Asociación para Evitar la Ceguera en México
Contact
Status	Withdrawn
Phase	Phase 4
Start date	June 2008
Completion date	June 2009

See also
Status	Clinical Trial	Phase
Terminated	`NCT00571142` - Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema	Phase 3
Recruiting	`NCT00999791` - Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema	Phase 1
Withdrawn	`NCT00600301` - Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study	Phase 3
Completed	`NCT00886808` - Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema	Phase 1
Recruiting	`NCT01218750` - Triple Therapy for Diffuse Diabetic Macular Edema	N/A